SleepCogni Limited

SleepCogni Limited, based in the UK, specializes in innovative sleep therapy solutions aimed at alleviating insomnia and enhancing sleep quality through advanced therapeutic devices. SleepCogni Limited operates in the health tech sector, focusing on sleep improvement solutions. Founded in 2015 in Sheffield, UK, the company has successfully raised GBP 300,000 in its most recent funding round. The company was established by Maan van de Werken, with Richard Mills as the CEO.

SleepCogni has completed six deals, with the latest occurring on December 17, 2024, and has raised a total of GBP 300,000 to date. SleepCogni primarily offers a sleep therapy device designed to assist users in overcoming insomnia and improving sleep quality. The device integrates tactile interaction and therapeutic techniques to calm the mind, aiding users in transitioning to sleep more easily. Targeting individuals suffering from anxiety and racing thoughts, the device has shown to significantly improve sleep quality within seven days, according to clinical trials.

The company is focused on accessibility for children and young adults and has partnered with Sheffield Children’s NHS Foundation Trust to expand its outreach. SleepCogni aims to market its products in the UK and the US, addressing a demographic of over 70 million individuals affected by insomnia. SleepCogni's revenue model primarily consists of direct-to-consumer sales of their sleep therapy device, with potential for partnerships with healthcare providers. The company has raised a total of GBP 300,000 to support its US market entry, contributing to a total funding of GBP 300,000.

Revenue is generated through individual purchases, with additional opportunities expected from collaborations with medical organizations to enhance distribution. Specific pricing details have not been disclosed as the company focuses on establishing its market presence in the sleep therapy sector. In December 2024, SleepCogni Limited raised GBP 300,000 in venture funding from unspecified investors. This funding will support its strategic plans for 2025, which include the development of new products and an international expansion initiative.

The company aims to enter new markets, particularly targeting the US, by the end of 2025, leveraging recent funding to enhance its operational capabilities and product offerings.